Mostrar el registro sencillo del ítem
dc.contributor.author | Datta, Sumona | |
dc.contributor.author | Sherman, Jonathan M. | |
dc.contributor.author | Bravard, Marjory A. | |
dc.contributor.author | Valencia, Teresa | |
dc.contributor.author | Gilman, Robert Hugh | |
dc.contributor.author | Evans, Carlton Anthony William | |
dc.date.accessioned | 2019-02-06T14:52:17Z | |
dc.date.available | 2019-02-06T14:52:17Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/5292 | |
dc.description.abstract | BACKGROUND: It is difficult to determine whether early tuberculosis treatment is effective in reducing the infectiousness of patients' sputum, because culture takes weeks and conventional acid-fast sputum microscopy and molecular tests cannot differentiate live from dead tuberculosis. METHODS: To assess treatment response, sputum samples (n=124) from unselected patients (n=35) with sputum microscopy-positive tuberculosis were tested pretreatment and after 3, 6, and 9 days of empiric first-line therapy. Tuberculosis quantitative viability microscopy with fluorescein diacetate, quantitative culture, and acid-fast auramine microscopy were all performed in triplicate. RESULTS: Tuberculosis quantitative viability microscopy predicted quantitative culture results such that 76% of results agreed within +/-1 logarithm (rS=0.85; P<.0001). In 31 patients with non-multidrug-resistant (MDR) tuberculosis, viability and quantitative culture results approximately halved (both 0.27 log reduction, P<.001) daily. For patients with non-MDR tuberculosis and available data, by treatment day 9 there was a >10-fold reduction in viability in 100% (24/24) of cases and quantitative culture in 95% (19/20) of cases. Four other patients subsequently found to have MDR tuberculosis had no significant changes in viability (P=.4) or quantitative culture (P=.6) results during early treatment. The change in viability and quantitative culture results during early treatment differed significantly between patients with non-MDR tuberculosis and those with MDR tuberculosis (both P<.001). Acid-fast microscopy results changed little during early treatment, and this change was similar for non-MDR tuberculosis vs MDR tuberculosis (P=.6). CONCLUSIONS: Tuberculosis quantitative viability microscopy is a simple test that within 1 hour predicted quantitative culture results that became available weeks later, rapidly indicating whether patients were responding to tuberculosis therapy. | en_US |
dc.language.iso | eng | |
dc.publisher | Oxford University Press | |
dc.relation.ispartofseries | Clinical Infectious Diseases | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Adult | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Young Adult | en_US |
dc.subject | Time Factors | en_US |
dc.subject | fluorescein diacetate | en_US |
dc.subject | early bactericidal activity | en_US |
dc.subject | multidrug-resistant tuberculosis | en_US |
dc.subject | Sputum/microbiology | en_US |
dc.subject | Antitubercular Agents/therapeutic use | en_US |
dc.subject | Bacteriological Techniques/methods | en_US |
dc.subject | Microscopy/methods | en_US |
dc.subject | Drug Monitoring/methods | en_US |
dc.subject | Microbial Viability/drug effects | en_US |
dc.subject | Tuberculosis/drug therapy | en_US |
dc.subject | viability stain | en_US |
dc.subject | vital stain tuberculosis | en_US |
dc.title | Clinical evaluation of tuberculosis viability microscopy for assessing treatment response | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1093/cid/ciu1153 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
dc.relation.issn | 1537-6591 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |